Table 15 Physicochemical properties of L1 and L2 DNA vaccine constructs.

From: In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine

construct

Epitope sequence (HPV-Type)

Antigenicity*

Molecular weight (Da)

Instability index of constructs

Solubility index of constructs**

In vivo half time

L1

EATVYLPPVPVSKVVA (16)

0.5397

28227

47.52(stable)

0.648(soluble)

>20 hours

DNTVYLPPPSVARV (18)

0.2280

DTYRFVTSQAIACQK (16)

0.1995

DTYRFVQSVAITCQK (18)

0.3133

YLPPVPVSKV (16)

1.0876

YLPPPSVARV (18)

0.4104

DQFPLGRKFLL (16)

0.2797

DQYPLGRKFLV (18)

0.6476

L2

PDFLDIVALHRPALTSR (16)

1.1115

25674

34.01(Stable)

0.407(soluble)

>20 hours

SDFMDIIRLHRPALTSR (18)

0.4570

FFGGLGIGTGSGTGGR (16)

1.0724

DPSIVTLIEDSSVVTSGAP (18)

0.4474

KRASATQLYK (16)

0.1484

KRASVTDLYK (18)

0.4778

DPDFLDIVALHR (16)

1.6210

DSDFMDIIRLHR (18)

0.3371

  1. *higher rate shows high degree of peptide antigenicity.
  2. **higher rate shows high degree of peptide solubility.